BioRestorative Therapies Inc.
BRTX | NASDAQ
$2.71
+$0.02 (+0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$2.66
-$0.05 (-1.85%)
Pre-market:
Sep 22, 2026, 8:40 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 359.7K | 401K | 145.8K | 119.8K | 46K | 77K |
Cost of Revenue | 23.84K | 28.07K | n/a | n/a | n/a | n/a |
Gross Profit | 335.86K | 372.93K | 145.8K | 119.8K | 46K | 77K |
Operating Income | -15.65M | -11.56M | -15.22M | -18.86M | -26.31M | -2.75M |
Interest Income | 266.21K | 616.08K | 552.29K | 11.65K | n/a | n/a |
Pretax Income | -14.24M | -8.98M | -10.42M | -13.22M | -44.3M | -11.27M |
Net Income | -14.24M | -8.98M | -10.42M | -13.22M | -44.3M | -11.27M |
Selling & General & Admin | 5.89M | 6.58M | 11.33M | 15.58M | 25.62M | 1.95M |
Research & Development | 10.09M | 5.35M | 4.03M | 3.51M | 729.06K | 876.83K |
Other Expenses | n/a | n/a | n/a | -110.52K | n/a | n/a |
Operating Expenses | 15.98M | 11.93M | 15.37M | 18.98M | 26.35M | 2.83M |
Interest Expense | n/a | n/a | n/a | n/a | 1.82M | 1.64M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 12.29K | 28.28K |
Cost & Expenses | 16.01M | 11.96M | 15.37M | 18.98M | 26.35M | 2.83M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 449.66K | 388.2K | 210.92K | 180.89K | 59.39K | 19.74K |
Shares Outstanding (Diluted) | 449.66K | 388.2K | 210.92K | 180.89K | 59.39K | 19.74K |
EPS (Basic) | -31.60 | -23.20 | -49.40 | -73 | -746 | -571.20 |
EPS (Diluted) | -31.60 | -23.20 | -49.40 | -73 | -746 | -571.20 |
EBITDA | -14.03M | -8.79M | -14.97M | -13.1M | -42.4M | -9.48M |
EBIT | -14.24M | -8.98M | -15.14M | -13.22M | -42.49M | -9.63M |
Depreciation & Amortization | 209.99K | 189.06K | 165.74K | 120.55K | 89.11K | 151.96K |
Add to Watchlist
Select watchlists to add or remove BRTX